Ivermectine Arrow Lab

Ivermectin, the active ingredient in Ivermectine Arrow Lab, is an antiparasitic presented as an oral formulation for oral use. It belongs to the macrocyclic lactone class and is employed to treat a range of parasitic infections, including onchocerciasis, strongyloidiasis, scabies and lymphatic filariasis, by targeting the parasites’ nervous system in affected individuals.

GNH USA supplies Ivermectine Arrow Lab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for regulated medicines.

Ivermectin is indicated for several parasitic diseases affecting the skin, intestines and lymphatic system.

Onchocerciasis: reduces microfilarial load and prevents disease progression. Strongyloidiasis: eradicates intestinal larvae and prevents hyperinfection syndrome. Scabies: eliminates Sarcoptes scabiei mites, relieving itching and skin lesions. Lymphatic filariasis: lowers circulating microfilariae, supporting mass‑drug‑administration programs.

Ivermectin may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that may resolve without treatment. - Dizziness: transient light‑headedness, especially after the first dose. - Diarrhea: loose stools occurring within days of administration. - Abdominal pain: cramp‑like discomfort in the stomach region.

Serious or Rare Side Effects: - Severe skin reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis.